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Abstract 
Objective 
With the increased complexity and uncertainty in drug information, issuing medical 
prescriptions has become a vexing issue. As many as 240,000 medicines are available 
on the market, so this paper proposes a novel approach to the issuing of medical 
prescriptions. The proposed process will provide general practitioners (GPs) with 
medication advice and suggest a range of medicines for specific medical conditions 
by taking into consideration the collective pattern as well as the individual preferences 
of physicians’ prescription decisions. 
 
Methods and Material 
A hybrid approach is described that uses a combination of case-based reasoning (CBR) 
and Bayesian reasoning. In the CBR process, all the previous knowledge retrieved via 
similarity measures is made available for the reference of physicians as to what 
medicines have been prescribed (to a particular patient) in the past. After obtaining the 
results from CBR, Bayesian reasoning is then applied to model the prescription 
experience of all physicians within the organization. By comparing the two sets of 
results, more refined recommendations on a range of medicines are suggested along 
with the ranking for each recommendation. 
 
Results 
To validate the proposed approach, a Hong Kong medical center was selected as a 
testing site. Through application of the hybrid approach in the medical center for a 
period of one month, the results demonstrated that the approach produced satisfactory 
performance in terms of user satisfaction, ease of use, flexibility and effectiveness. In 
addition, the proposed approach yields better results and a faster learning rate than 
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when either CBR or Bayesian reasoning are applied alone.  
 
Conclusion 
Even with the help of a decision support system, the current approach to anticipating 
what drugs are to be prescribed is not flexible enough to cater for individual 
preferences of GPs, and provides little support for managing complex and dynamic 
changes in drug information. Therefore, with the increase in the amount of 
information about drugs, it is extremely difficult for physicians to write a good 
prescription. By integrating CBR and Bayesian reasoning, the general practitioners’ 
prescription practices can be retrieved and compared with the collective prescription 
experience as modeled by probabilistic reasoning. As a result, physicians can select 
the drugs which are supported by informed evidential decisions. That is, they can take 
into consideration the pattern of decisions made by other physicians in similar cases. 
 
 
Keywords: Bayesian reasoning; Case-based reasoning; Decision support system; 
General practitioners; Medical prescription 
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1. Introduction 
Medical prescription is facing the challenge of increased complexity and uncertainty 
from the very great increase in information on new drugs. Nowadays numerous new 
drugs are being developed and launched to treat new diseases. With the growing 
amounts of information, medical prescriptions made by physicians have become a 
contentious issue. This is particularly true from the general practitioners’ (GPs) 
perspective. The explosive growth of data requires them to learn and remember many 
details so they can prescribe the right medication, in the right amount, for the right 
patient. The possible approaches to dealing with this problem are by means of 
electronic medical records (EMR) [1-5] and clinical decision support systems (CDSS) 
[6-10]. Through knowledge discovery from these disciplines of medical informatics, 
the medical prescription process can be facilitated and hence the quality of 
prescription decisions can be improved [46]. 
 
However, decision support for medical prescription provided by the existing medical 
informatics disciplines lacks flexibility in selecting and delivering relevant drug 
choices to physicians. The existing medical prescription support system can only 
assist medical experts in providing a better understanding of the problem in-hand by 
pooling the diagnostic experience of many physicians [2,11,12]. In this way, these 
approaches are limited to suggesting drugs based on diagnosis classification. The 
advice is far too vague to meet the real needs of therapeutic situations. To improve 
this situation, capturing specific knowledge from past medical cases can generate 
substantial and relevant knowledge in support of the prescription process of GPs. 
 
In each diagnostic process, previous knowledge stored in medical records is important 
to physicians for making prescription decisions [39]. Case-based reasoning (CBR), a 
well-known problem solving technique that is capable for retrieving the most relevant 
cases that are most similar to the problems being diagnosed [45], is used to represent 
the prescription knowledge accumulated from specific situations. It is noted that drug 
recommendations extracted from the most relevant cases may not be appropriate for 
the problem at hand, Bayesian reasoning that discovers the general prescription 
patterns of physicians is thus employed to fine tune the medical prescription options, 
based on what medication is probably the most suitable, given a certain diagnosis and 
certain symptoms. These are distinct techniques, each with its own strengths and 
limitations. To the authors’ knowledge, they are also seldom integrated together, 
particularly in the prescription domain. In other words, a “micro-view” of specific 
knowledge (modeled by CBR) and a “macro-view” of general knowledge 
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(represented by Bayesian reasoning) are formulated and are leveraged using each 
other’s strengths.  
 
This paper proposes a hybrid knowledge-based approach to support medical 
prescription (HKSMP), as a complement to the existing statistical approach proposed 
in [2]. HKSMP incorporates CBR and Bayesian reasoning approaches in helping 
physicians to perform flexible prescription, in providing medication advice, and 
anticipating a range of medicine for the physicians. Furthermore, HKSMP is the first 
model that has attempted to handle the prescription solution by considering both 
specific knowledge and general knowledge. A case study in a Hong Kong medical 
centre is presented to illustrate the implementation of the proposed system and to 
validate the practicability in a real world application.  
 
The remainder of the paper is organized as follows. Section 2 briefly reviews the 
relevant literature on common practices for medical prescription, and the application 
of CBR and Bayesian reasoning in the domain of interest. Section 3 illustrates the 
hybrid knowledge-based approach. A case study in applying this approach is 
elaborated in Section 4. Results are presented and discussed in Section 5. Finally, 
Section 6 concludes with a discussion and proposals for future research directions. 
 
2. Research Background 
2.1 Electronic medical record systems and decision support systems in medical 
prescription 
A medical prescription is a medication order form written by a qualified medical 
professional [3]. It serves as a medium of communication between the physician and 
the pharmacist/nurses to ensure that the right medication is delivered to the patient. 
Fig. 1 depicts the medical prescription practices among physicians, nurses, 
pharmacists and patients. However, with voluminous drug information (i.e. more than 
240,000 prescription drugs on the market) [34], it is not easy for medical experts to be 
knowledgeable and familiar with the use of different drugs and with dosage 
instructions. Even with the same diagnosis, the medical prescription may differ from 
one patient to another as the patient’s age and physical condition must also be taken 
into consideration in the prescription. This is especially the case for GPs as they are 
primarily responsible for providing comprehensive health care to individuals seeking 
medical care, and for making arrangements for other health care personnel to provide 
specialist services when necessary [13]. Thus, learning about new drug information, 
and remembering the appropriateness and possible contradictions of a large number of 
drugs remain open challenges for GPs [14,15].  
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Many researchers have suggested that applying technology in medical practices can 
help GPs to stay informed about the latest development of drugs and thus can help to 
reduce medical errors and improve patient safety. To support the decision making 
process of the medical experts, Electronic Medical Records (EMR) have been 
introduced to transform the traditional handwritten medical records into digital ones. 
Rector et al. [4] present a model for an electronic medical record system which 
provides a permanent, complete record of patient care and the medical decisions made. 
Kohane et al. [5] applied client-server technology of the World Wide Web to design 
national electronic medical record systems (EMRSs). Hammond et al.’s study [16] has 
demonstrated that using EMR not only can improve the quality of patient care and 
decrease medical errors, but also can result in a positive financial return on investment. 
With such a sound financial achievement of EMR, many researchers are focusing on 
how to integrate medical records with decision making tasks. Shiffman et al. [17] and 
Linnarsson [18] claimed that integration of EMR with a decision support system (DSS) 
can enhance effectiveness in ensuring patient safety. The benefits of current DSSs 
used in general practice include assisting doctors in performing diagnosis, disease 
prevention, enhancing decision making quality in the primary care consultation and in 
selecting appropriate dosage [19]. All these are in line with Wang et al.’s results of a 
5-year study [20].  
 
DSS always have long been used by different industries to solve different problems 
that range from prediction, forecasting and data classification. For example, Panda et 
al. [40] and Chang and Liao [41] applied soft computing techniques to predict flank 
wear in drills and flow time in semiconductor manufacturing factories, respectively. 
The application of DSS in the medical domain has been mostly developed to provide 
physicians with advice on either diagnosis or treatment by means of artificial 
intelligence (AI) and Bayesian reasoning [21]. Because of the complexity of drug 
information, DSS demonstrates great potential in the area of medical prescription, 
however, only a few publications have addressed this issue. One of the publications, 
proposed by Warren et al. [11], describes how drug choices can be reduced after 
specifying the diagnosis; but it lacks consideration of physicians’ prescription patterns 
and the patients’ clinical background information. In this case, it can satisfy the ‘five 
rights’ (i.e. the right drug, the right dose, the right time, the right route and the right 
patient) of medication administration [35], which is a crucial standard of health care. 
Therefore, a more comprehensive medical prescription support approach is required 
to ensure the right medication of the right amount are administered to the right 
patient. 
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2.2 Knowledge discovery in medical prescription by Bayesian reasoning 
Knowledge discovery is another popular research topic in medical informatics. It is a 
process that uses data mining algorithms to extract and identify what can be 
considered as knowledge from a large volume of data [22,23]. With the aid of 
computerization of medical records, all the individual diagnosis transactions are 
collected and stored, thus forming a data warehouse that stores the collective 
behaviors of the medical practices within the organization. Lian et al. [12] has pointed 
out that the prescription is specified by a preference function based on the user's 
preference in prior clinical experience. Thus, they propose a dose optimization 
framework based on probability theory. Susan and Warren [2] demonstrated that the 
conditional probability model is superior in optimizing the drug lists to the multiple 
linear regression and discriminant analysis models. The strong relationship between 
diagnosis and medication allows one to determine a posterior probability (what 
medication is needed) based on a priori probability (what diagnosis has been made) 
[11].  
 
Conditional probability is a popular statistical modeling technique in Bayesian 
reasoning that studies the probability that one event happens given that some other 
event has happened. In the medical domain, conditional probability is particularly 
useful in prescription decision support, because it can quickly determine the 
probability of a certain drug being required if a certain diagnosis has been made. 
Spenceley et al. [24] argued that their model, based on the conditional probability, can 
reduce prescription choices by more than a half when compared with the conventional 
model. Nevertheless, it relies heavily on diagnosis classification, and there could be 
some problems such as the failure to take physician’s prescription pattern and 
patient’s details (such as allergy to specific medicine) into consideration.  
 
2.3 Case-based reasoning in medical prescription 
In recent years, the concept of knowledge-based systems has gained acceptance in 
both medical diagnosis and medical prescription. An important task in a 
knowledge-based system is to support human decision making, learning and action by 
extending and querying the knowledge base. In the area of medical informatics, a 
knowledge base is typically useful in supporting the decision making involved in 
medical prescription [19]. Over the past two decades, numerous knowledge-based 
techniques have been successfully applied to prescription [7,27]. However, Schmidt et 
al. [29] argued that CBR is the one technique which is particularly suitable for 
medical knowledge based systems.  
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CBR is a plausible generic model of an intelligent and cognitive science-based 
method as it gives users much more information for situation assessment [30]. With 
its cognitive model, CBR can describe past experience and hence retrieve similar 
cases or solutions. In other words, it is an intelligent problem-solving model that 
relies on the reuse of past practices to tackle new problems. To achieve accurate 
results, CBR needs to undergo a revision process by modifying the cases and has to 
store revised cases in the database for solving future problems. The benefits of 
applying CBR applications to medical prescription include responsiveness to changes, 
being easy to set up, having the ability to capture domain knowledge, flexibility (i.e. 
supporting dynamic behavior), and providing intelligent decision support. Recently, 
CBR has attracted considerable research interest to support the selection and 
recommendation of treatment. Zhuang et al. [36] combined data mining and CBR 
methodologies to provide GPs with intelligent decision support for pathology tests 
ordering. They guarantee that the integrated system can enhance the testing ordering 
in terms of its evidence base, situational relevance, flexibility and interactivity. Huang 
et al. [37] proposed a model of a chronic diseases prognosis and diagnosis (CDPD) 
system by integrating data mining and CBR to support the treatment of chronic 
diseases. Khan and Hoffmann [38] presented an approach that allows GPs to 
automatically construct a menu which is strongly tailored to the individual 
requirements and food preferences of a client. Concerning medical prescription 
practices, Marling and Whitehouse [31] developed AUGUSTE to support treatment 
planning in Alzheimer’s disease by using CBR to determine if a neuroleptic drug 
should be prescribed and then to select the approved drugs for a patient via a 
rule-based mechanism. Hartge et al. [32] proposed a similarity measurement 
algorithm for a CBR system to support drug-related events in minimizing 
inappropriate selection of drugs and inappropriate drug-drug interaction. In these 
applications, CBR provides a potential extension to support the medical prescription 
process.  
 
With sound results in applying CBR for problem-solving in the medical domain, 
several researchers argued that the chance of reusing a case from CBR is not high in 
some areas, such as insurance claims prediction [42] and multiple medical disorder 
cases [43]. Such a statement is also true in the domain of prescription support. Since 
the solution of a prescription case typically involves multiple medicines, not all the 
medicines are effective in addressing the problem in a new case. Thus, further 
modification of CBR is required to improve the accuracy of selecting the appropriate 
set of medicines in prescription support. However, very few research studies and 
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empirical investigations have been done for prescription related topics. Therefore, the 
HKSMP method proposed in this paper focuses on improving the solution extracted in 
CBR and providing relevant and objective evidence in prescription decision support. 
Furthermore, CBR and Bayesian reasoning are often applied separately. The HKSMP 
approach proposed is based on a parallel flow of CBR and Bayesian reasoning. The 
work differs from the above studies in that it combines the results of CBR and 
Bayesian reasoning by adopting rule sets. In contrast to the traditional methodologies 
which provide simplistic suggestions at a specific point in time, the proposed 
methodology is capable of providing suggestions (i.e. medicines to be prescribed) at 
any stage after clinical judgments have been made by physicians. The HKSMP 
proposes a novel measure that adopts an “ensemble learning method” [44] in 
combining the solutions of CBR and Bayesian reasoning by means of a rule base 
rather than choosing among them, thus getting solutions that outperforms those 
obtained from any single one of the models, so as to assist the physicians in 
identifying a medication list that is suitable for the patient. 
 
3. Hybrid Knowledge-based Approach to Supporting Medical Prescription 
(HKSMP) 
Given a set of historical medical prescription records stored in a knowledge base, the 
objective of HKSMP is to suggest a range of medicines from which physicians can 
choose. In general, Fig. 2 depicts the logical view of HKSMP. The approach starts 
when the physicians input the symptoms and diagnosis of the patient, and ends with 
the solution (i.e. suggested medicines) generation. All details in the approach are 
discussed in the next section. 
 
3.1 Concept of ‘Micro-view’ and ‘Macro-view’ 
In each diagnostic process, the physician may reuse previous solutions in relevant 
situations to address the new problem. Therefore, we apply the CBR approach 
proposed by [36] to specifically retrieve previously experienced cases with 
information on concrete problem situations and their solutions. As each retrieved case 
represents a particular patient’s medical history on the basis of a physician’s specific 
knowledge of the prescription practices, the solution obtained in the CBR process 
relates a specific patient to the physician (i.e. patient-centric). When a patient has 
consulted several physicians in the past, more knowledge in diagnostic and 
prescription decisions related to that particular patient will have been acquired. The 
associated network, that formulates a patient-physicians relationship, represents a 
‘micro-view’ in the medical data (Fig. 3a). 
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On the other hand, when applying Bayesian reasoning, the prescription patterns of the 
diagnostic experiences within the organization can be captured and characterized 
through a probabilistic measure. Such statistical approximation expresses the 
knowledge that is accumulated from all the physicians, thus the solution obtained in 
Bayesian reasoning depicts a peer-based relationship among the physicians. The 
associated network, at this time, centers on the characteristics of the whole 
organization. The physician-physicians (within the organization) relationship, thereby 
forms a ‘macro-view’ in the medical data (Fig. 3b).  
 
3.2 Algorithm of the Hybrid Model  
As shown in Fig. 2 and Fig. 4, the universal set of drugs captured from the EMR will 
first pass to the HKSMP to serve as the drug bank for the preparation of the 
recommended medical prescription list for the GPs. Results of diagnoses made by a 
physician are entered into both the CBR and Bayesian reasoning processes within the 
model for extraction and discovery of the pattern of the drugs prescribed. The two 
drug sets generated from the model (i.e. one from CBR and another one from 
Bayesian reasoning) are combined via a set of ‘IF-THEN’ statements (i.e. rule-based 
results aggregator) to obtain the solutions. If a drug appears in the results of CBR as 
well as Bayesian reasoning, it is classified as a recommended drug to fit the new 
situation. In this regard, the results from CBR and those from Bayesian reasoning 
supplement each other to provide an intelligent way of optimizing the drug choices. 
Furthermore, HKSMP can explain whether the past prescription was effective or not. 
 
3.2.1 Retrieving the micro-view of prescription behavior 
The provision of the micro-view of prescription behavior is the main concern of the 
recommended prescription solution. Different GPs may have their own prescription 
practices and style (in the use of drugs), therefore CBR will help GPs to make 
informed drug choices with references to the old cases stored in the knowledge base. 
The proposed approach first retrieves a set of similar cases from the case base through 
the nearest-neighbor retrieval (NNR) technique, and hence evaluates the similarity 
between each case in the database. In HKSMP, a case contains the medical 
information of the patient such as the patient’s demography, treatment and 
administrative data (including age, sex, treatment date, symptoms, diagnosis, payment, 
number and duration of sick leaves). We then use the numerical function of NNR to 
compute the similarity between stored cases and newly input cases using weights 
assigned to applicable features. As suggested by Kolodner [30], these weights are 
assigned by human experts, as these experts are expected to be knowledgeable and 
experienced in determining which dimensions make good predictors. In measuring the 
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degree of similarity between cases, weighted Euclidean distance measurement is used. 
The degree of similarity between cases is formulated by Eq. (1). 
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The drug list which is presented shows the past cases which have the highest degree 
of similarity to the present case. The solution of CBR can be represented as follows: 
 
},...,,,{ niiiiii cbrdrugcbrdrugcbrdrugcbrdrugnCBRsolutio   (2) 
where icbrdrug  to ncbrdrug  are the medicines prescribed in the retrieved case 
 
Before producing the solution to the user, the retrieved cases will be adjusted by the 
result from Bayesian reasoning in order to identify what drugs have been prescribed 
in similar situations by other medical experts, without losing the general prescription 
practices.  
 
3.2.2 Retrieving a macro-view of prescription behavior  
The objective of forming a macro-view is to model the existing knowledge of 
prescription behavior as peer-based evidence to facilitate prescription support and 
complement the results of the micro-view. To determine the macro-view of the 
prescription behavior, Bayesian reasoning is used to build a model of the conditional 
probability of drugs being prescribed, given the diagnosis selected [2].  
 
In order to guarantee that the previous mistakes in the prescription of drugs are not 
repeated, a set of rules showing the relationship between diagnosis and drug 
properties are evaluated and approved by the physicians for ensuring the quality of the 
modeling. An example of the rules is for Mylanta that is used to treat acid indigestion, 
heartburn, and sour stomach. These rules are stored in the database and can be 
modified if necessary (for example, if a new side-effect of a particular drug is 
discovered). The pre-defined rules therefore filter the drug choices according to the 
diagnoses chosen by the physicians at each patient visit. The remaining appropriate 
drug will then be determined by the conditional probability of the drugs required. This 
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is based on the co-occurrence of specific drugs with the selected diagnosis. Generally, 
a conditional probability in Bayesian reasoning demonstrated in Eq. (3), in which 
)|( diagnosisdrugP i  is a posterior probability of idrug . 
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For the situation where one patient has multiple diagnoses, we will first look up the 
data warehouse to find the exact cases that persisted previously. If a matching result 
can be found, it will follow the conditional probability defined in Eq. (3) to compute 
the ranking. However, if there is no matching result, we will apply an approximation 
mechanism from the fuzzy set theory illustrated in Eq. (4). All the candidates are 
ranked by the  operator. For example, if the patient has the diagnosis of “upper 
respiratory tract infection (URTI), gastroenteritis, and dermatitis”, drugs are ordered 
according to the highest probability of occurrence among the three diagnoses. 
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Thus, the solution of Bayesian reasoning can be represented as follows: 
 
},...,,,{ niiiiii baydrugbaydrugbaydrugbaydruglutionBayesianso   (5) 
where ibaydrug  to nbaydrug  are the medicines prescribed in descending order, 
based on the probability result 
 
3.2.3 Rule-based results aggregator  
The objective of the rule-based results aggregator is to match the results between 
CBR and Bayesian reasoning. In the matching algorithm, the ranking of drugs is 
represented in the form of three different ‘IF-THEN’ statements as shown in Fig. 5.  
 
The first statement classifies the drugs which appear in both CBR and Bayesian 
reasoning, into Rank A, which is the top ranking recommended list, for the 
physician’s consideration. However, if the drugs do not match any instances (neither 
in CBR nor in Bayesian reasoning), they will be classified as Rank C. For the 
remaining prescribed instances (the drugs appear either in CBR or Bayesian 
reasoning), they will be grouped into Rank B. Since CBR considered more features 
related to the case, it is perceived that the result of CBR is more relevant to the new 
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situation. Thus, the drugs recommended from CBR will be placed higher on the list in 
Rank B, whereas the drugs from Bayesian reasoning will be placed lower down on the 
list in Rank B. An example of such illustration can be found in Fig. 6. Furthermore, 
the prescribing pattern of the physician can even be visualized and compared with the 
pool of prescriptions of many physicians. The physician can learn from this 
comparison. The entire rule-based results aggregator is repeated until all the drugs are 
categorized into corresponding areas. Thus, the final solution in the combined 
medication list is represented as follow: 
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(6) 
 
In HKSMP, the appropriate drug choice is optimized concurrently with the matching 
algorithm and illustrated as a ranking list to promote the flexibility and possibility of 
considering both individual behavior and collective behavior. Because of the complex 
nature of prescribing, the recommended medicine selection list serves only as a 
reference for physicians which they can use for quick identification of the relevant 
medicines from past experience. The physician can deviate from the recommendations 
at any time as they have complete autonomy; thus the final decision still rests with the 
individual physician. 
 
3.2.4 Retaining the solution in the knowledge base  
Once the physician selects the medicines to be prescribed, HKSMP has achieved its 
goals. The new problem situation and its corresponding solution are then be stored in 
the database automatically. Such a retaining process is considered as the actual 
learning process for facilitating the GPs future decision making on drug prescription. 
 
4. Case Study 
In order to demonstrate the hybrid approach described above, an EMR with an 
intelligent prescription system was designed on the basis of the HKSMP and then 
applied in a Hong Kong medical centre named Humphrey & Partners Medical 
Services Limited (HPMS). It was found during the study that by using the intelligent 
prescription system, the medical prescription process was more effective and more 
accurate than the method used previously (see Section 5). The case study is described 
below. 
 
4.1 Case study background 
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HPMS is one of the largest multi-disciplinary medical services providers in Hong 
Kong. It was founded by a team of dedicated medical practitioners, and consists of 4 
core clinics located in different parts of the city and about twenty medical experts 
working on a rotational basis to provide various, high quality medical services to its 
patients. The general practice in a treatment consists of several steps, including patient 
registration, GP diagnosing, medical prescription and delivery of drugs. At HPMS, 
GPs find the current medical information system is not user friendly as they find it 
difficult to identify and choose the drugs (from two hundred drugs available in the 
clinic) required for the treatment; which makes the prescription process more 
complicated. Thus, EMR in intelligent medical prescription support system can 
support GPs to easily and quickly retrieve the patient information for the whole 
treatment process. The hybrid model can thus help the GPs to look up and select the 
required drugs efficiently by ranking the drugs based on diagnosis and on the doctor’s 
individual method of prescription.  
 
4.2 An illustrated example – from EMR to intelligent medical prescription support 
The hybrid approach has been tested in HPMS to validate the feasibility of this 
solution in an actual operational environment. Totally, seven phases are involved in 
building the EMR and HKSMP (Fig. 7). An EMR system with a knowledge-based 
medical prescription support approach is first introduced to the GPs in two different 
HPMS clinics within the period 1
st
 March 2009 to 31
st
 March 2009.  
 
4.2.1 Phase 1: Diagnosis by medical expert 
The system interface for the GPs to make treatment is shown in Fig. 8. After 
registering in EMR, the patient information, including patient name, sex, age, 
allergies, past medical history, are transferred to the GP’s computer. In order to obtain 
a better result in the hybrid approach, the symptoms and diagnosis are pre-defined in 
the system, in which GPs just simply select and check the box under the 
symptoms/diagnosis column. On the other hand, for those symptoms and diagnosis 
that have not been encountered before, an input area is designed for GPs to type in 
specific information.  
 
4.2.2 Phase 2: Pre-processing of cases 
This phase focuses on turning the data warehouse into a data mart for easy access to 
frequently needed data. Before retrieving the cases to find similar solutions, a 
pre-processing method is used to index and extract the specific information from the 
data warehouse. Some irrelevant data is removed in the knowledge base. For example, 
“referral” does not have any effect on the decisions made in drug prescription and is 
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thus removed.  
 
4.2.3 Phase 3: Retrieving the solution from cases 
After the GP decides the diagnosis and the pre-processing phase, all the relevant 
information is gathered to perform the CBR process. Table 1 summarizes the 
attributes for case featuring. It involves the patient information and past treatment 
details (such as last record, number and duration of sick leaves, payment, diagnosis, 
symptoms, additional services). Before storing in the case base, all these cases will be 
validated by the board of directors (BODs) in HPMS who are specialists in various 
medical disciplines. With their experience, all the stored cases are validated and the 
collection of these cases covers a wide range of illnesses treated by a large group of 
physicians. The main purpose of CBR is to retrieve similar cases of patients suffering 
from the same condition. If the diagnosis and patient information match perfectly with 
the existing case, the solution of the existing case will be used as the reference to the 
physician without any change. However, if no exact match is found, Eq. (1) is applied 
to retrieve and propose the most appropriate medical prescription list. All the weights 
of the features are given by the BODs in HPMS. On the basis of the data captured 
from EMR, the BODs discuss the weightings one by one and finally reach a solution. 
This helps in ranking all the cases in the knowledge base. A typical case in the 
knowledge base is shown in Fig. 9. It contains the problems (description of the 
treatments with patient information) and the medical prescription choice with the 
probability for further matching (See Section 4.2.4).  
 
4.2.4 Phase 4: Computing the probability of drugs being prescribed given the 
diagnosis 
By using Eq. (3) and Eq. (4) to generate the conditional probability, we can rank all 
the drugs prescribed in descending order of probability based on the input from phase 
1. The probability is computed based on the frequency of drug selection captured 
from the past instances of prescription. Fig. 10 illustrates an example of the 
probability of drugs prescribed if the diagnosis is URTI and under the ‘WP001’ clinic.  
 
4.2.5 Phase 5: Matching the two results 
It is realized that the experience of GPs is directly proportional to the number of cases 
they have dealt with. Therefore, this phase aims at combining the results from the two 
different models by weighting with their experience in order to reduce the bias of the 
drug choice. Similar to phase 2, the weight is provided by the BODs with reference to 
the number of visits to the GP, past history and patient revisit rate. The weight is 
adjustable from low to high (on a scale from 0 to 100%). This is useful when there is 
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a change in performance of a particular GP.  
 
4.2.6 Phase 6: Generating an intelligent medical prescription list 
After combining the results from phase 4, the GP can have the recommended medical 
prescription list regarding to the patient’s problems. Thus, the most commonly 
prescribed drugs from two different models will be placed on the top, whereas the 
remaining drugs will be ranked in descending order of the probability of their being 
prescribed. Fig. 11 shows the final result of the recommended medical prescription 
list. 
 
5. Performance evaluation and discussion 
After implementing the hybrid knowledge-based medical prescription support 
approach to facilitate decision making in the drug selection process, the performance 
result is compared with those derived from the existing experience-based approach 
(i.e. based on the human experience and knowledge to make the prescription). Ten 
GPs work on rotation in two different clinics and they use the system in the course of 
their normal work. They were invited to provide user feedback about the usage of the 
system through interviews. The purpose of the interview was concerned with the 
following dimensions: 
 
 User satisfaction – Is the system useful for them? 
 Ease of use – Is it easy to learn and use? 
 Flexibility – Is it easy to cope with developments in the future? 
 Effectiveness – Can the system provide the appropriate prescription references to 
GPs? Can the system reduce errors in prescription? 
 
The result of the user feedback is illustrated in Table 2. From the result, it is found 
that the physicians agree that the system can improve their work in the different 
dimensions mentioned above; and GPs are willing to use it in future.   
 
Furthermore, as one of the objectives of HKSMP is to complement the existing 
statistical approach proposed by [2], real case data that collected from HPMS were 
randomly selected from the database for verifying the retrieval correctness between 
the hybrid approach and the separation of approaches (i.e. CBR and Bayesian 
reasoning). Each medical record contains a particular patient’s medical information, in 
which all the attributes are shown as Table 1. Since the study scope focuses on GP 
prescription, only GP-related patient records were retrieved and used in this 
experiment. In total, 500 cases which ranged from 1
st
 March 2009 to 31
st
 March 2009 
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were used. One experiment was used to measure the retrieval correctness of the 
medicine(s) generated by the HKSMP, whereas another one was used to measure the 
hit rate in each rank of HKSMP. 
 
5.1 Experiment 1: Evaluation of the retrieval correctness among the three approaches 
According to the general practices in HPMS, physicians usually prescribe 5 to 7 
medicines to a patient. Therefore, the focus of this experiment was to investigate the 
retrieval correctness of the top 5, 6, and 7 suggested medicines recommended by 
HKSMP. It was found that the three approaches may recommend more than 7 
medicines, therefore only the top 5, 6, and 7 medicines suggested were used in this 
evaluation. The leave-one-out method was then used as the validation method for 
determining how accurately a learning algorithm will be able to predict data that it 
was not trained on. In this method, the learning algorithm was trained multiple times, 
using all but one of the training cases. This validation method is useful because it does 
not waste data. Correctness, in this paper, refers to the ratio of the number of correct 
medicine(s) produced by the approaches among the total number of medicines 
actually prescribed. An example of calculating the correctness is shown below:  
 
Suggested medicines recommended by an approach: {Drug A, Drug B, Drug C} 
Actual prescription result of physicians: {Drug A, Drug B, Drug D, Drug E} 
 
Correctness = No. of correct medicines / Total no. of medicines actually prescribed 
  = {Drug A, Drug B} / {Drug A, Drug B, Drug D, Drug E} 
  = 2 / 4 
  = 0.5 
 
To verify the scalability of the proposed approach, experiments were carried out with 
different numbers of training cases (i.e. 100-500 cases with increments of 100 cases). 
Also, equal feature weightings were used in the CBR and HKSMP analysis. Only the 
first most similar case was retrieved in the CBR analysis. Accuracy analysis as 
mentioned above was then applied for the performance measurement by comparing 
the suggested solutions of the three analysis method against the actual solution. The 
experimental setup is depicted in Fig. 12. 
 
Table 3 shows the results of solution retrieval correctness among the three different 
approaches. On average, it was found that the proposed approach performs best and 
results in faster learning than either CBR or Bayesian reasoning alone, because the 
integration takes advantages of both individual and collective wisdom in the medicine 
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prescription process. In addition, HKSMP has a higher retrieval correctness when the 
number of learning cases increases. The figure reveals that the combination of the two 
approaches (i.e. HKSMP) outperforms the current approach to medical prescription 
support proposed by Bayesian reasoning and CBR alone.  
 
5.2 Experiment 2: Evaluation of the hit rate in the three ranks of HKSMP 
As proposed, three different ranks (i.e. Rank A, B, and C) are introduced in Section 
3.2.3. To verify the performance in each rank (i.e. the ratio of the number of correct 
medicine(s) produced in each rank among the total number of existing relevant 
medicine(s) in each rank), we measured the hit rate of GPs in each visit. After the 
clinical investigation performed by the physician, a range of drugs will be 
recommended and listed under Rank A, B or C. The hit rate refers to the number of 
matches between the HKSMP’s recommendations and the drugs actually prescribed 
by the physicians. The experiment setup is depicted in Fig. 13. 
 
The results of performance evaluation in different ranks are shown in Table 4. It is 
noted that the hit rate of solution retrieval of Rank B is higher than that of Rank A and 
Rank C because most of the medicines are obtained using either CBR or Bayesian 
reasoning. From the result, the suggested medicines allow the physician to decide on a 
prescription because on average at least one medicine has been prescribed in each 
rank. Furthermore, most of the medicines that will be prescribed can be found in 
either Rank A or Rank B, in which physicians can select around 2 to 3 medicines (out 
of the actual solution of 5 to 7 medicines being selected) in the recommended 
medication list in HKSMP. These results show that the proposed system allows 
physicians to identify the required drugs easily.  
 
5.3 Impact of HKSMP: Ethical issues 
As explained in previous discussions, the use and applications of HKSMP is proven to 
be beneficial and advantageous in the medical field. This is because the use of such a 
system focuses on the efficiency and efficacy of providing appropriate medication to 
different diseases encountered by GPs. It also assists healthcare professionals in 
supporting prescription decisions in terms of past medical knowledge applied by other 
physicians. Indeed, HKSMP poses several positive effects and advantages in the 
decision support in medical prescription. However, a number of negative impacts can 
be identified, which can be perceived as ethical issues related to the use of the system.  
 
The decision making process of GPs is first considered as an ethical issue. It is noted 
that few physicians might have the perception that HKSMP was designed as an 
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autonomous system that replaces their human judgment. In this way, the right of a 
patient to obtain the best form of medical treatment or service is assured. Given that 
HKSMP aims to enhance knowledge in the medical prescription process, a list of 
appropriate medicines (instead of several medicines) will be generated in the system. 
In this regard, physicians can make use of this information (or they may even ignore 
the information) and their own clinical judgment to provide the most suitable 
medication to a patient. In other words, it is important to let the physician understand 
that the proposed system is a kind of decision support tool on which they should not 
completely rely in making decisions.  
 
Another ethical issue is related to privacy and confidentiality of the information 
provided by the patients and physicians. It is recognized that HKSMP makes use of 
the electronically stored health information to infer the medical prescription decision 
support. In this way, the privacy and confidentiality of the information provided by a 
patient is not entirely recorded in the EMR, but rather it is retrieved for use in the 
HKSMP. It is claimed that confidentiality and privacy might be threatened with the 
use of such a system. Thus, one of the solutions to counteract this issue is to get the 
consent of patients, making them understand that the information is used for 
enhancing the case base of the system and will not be used for other purposes such as 
education and commercial purposes. Another solution is to introduce carefully 
thought-out policies that outline the system use of permissions and restrictions to 
reduce any ethical lapses.  
 
5.4 Limitations of the study 
The limitations of both CBR and Bayesian reasoning have been mentioned earlier (i.e. 
it is impossible to rely solely on past experience to treat the current situation), and it 
was observed that our approach works excellently when the patient condition in each 
visit was similar. In this case study, we found that more than 75% of the visits were 
similar to each other (e.g. the patients got similar or the same diagnoses) in which the 
drug selection is nearly the same as the previous visit. This may be due to the reasons 
that GPs employ the same rules or standards to treat the patients for the same diseases 
each time. On the limitation of the case study and the experimental set-up, the size of 
the knowledge base (i.e. the company and GPs involved) and the number of drugs 
available in the database are too small. IT is aware that the relatively small data set 
does limit the findings of the study, however it is believed that the results obtained 
show that HKSMP could be applied to a larger store of records in making suggestions 
on a range of medicines that could be used in medical prescription. Normally, more 
information can provide better decision support in CBR and Bayesian reasoning. As 
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the approach can be launched in other medical centers, the knowledge base and drug 
information have the potential to grow rapidly, and become more knowledgeable to 
support the current complex medical prescription problems. It is also interesting to 
note that even though making the prescription is a complex process involving 
numerous variables (up to a hundred) in making decision, the proposed hybrid 
approach can greatly assist the domain expert by reducing the prescription choices 
and by identifying appropriate medicine for the physician’s consideration. There is 
considerable saving in time compared with the conventional statistical approach for 
retrieving the previous prescription of each patient.  
 
6. Conclusion remarks and further research 
A hybrid knowledge-based decision support approach capable of extracting 
comprehensible individual and collective prescription behavior with good accuracy in 
medical prescription is proposed in this paper. With the growth in the amount of 
information about drugs, it is difficult for physicians to make a good prescription 
without a flexible drugs list. Mistakes in prescription are not only harmful but in 
serious cases they can also be fatal. The hybrid knowledge-based approach presented 
makes use of CBR to retrieve the micro-view of the physician’s practices and 
Bayesian reasoning to model the macro-view. Subsequently, a rule-based results 
aggregator is introduced to match the results and hence categorize them intelligently 
into a drug list. The physician can then select the drugs that he or she will prescribe by 
taking into consideration the decisions made by a number of other physicians who 
treated similar cases. 
 
The proposed hybrid approach has been validated in a medical center. The satisfactory 
results demonstrate the potential for adoption of this method in various medical 
organizations. However, there is still room for further development. Further research 
will consider more factors to determine the recommended drug lists. For example, 
combining the drug supply chain concept can further improve the results of drug 
selection. In addition, mining the relationships between drugs can generate more 
precise drug lists. Thus, we will extend our hybrid approach for medical prescription 
to take more and different factors into consideration.  
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List of Figures: 
 
 
Fig. 1. Relationships between physicians, pharmacists and patients in general medical 
prescription practice 
 
 
 
Fig. 2. Logical view of HKSMP 
 
 
Fig. 3. Assuming that a Patient A has visited and diagnosed by various physicians, (a) 
shows the patient-physician relationship in ‘Micro-view’ and (b) shows the 
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physician-physician relationship in ‘Macro-view’ 
 
 
Fig. 4. Interaction between physician and HKSMP 
 
 
 
 
 
 
 
 
 
 
 
 
 
Input: Results in CBR and Bayesian reasoning 
Output: A set of medicines in three different ranking list 
 
Rule-induction matching algorithm 
FOR EACH (drug name) 
     IF (the drug name in both CBR and Bayesian reasoning) THEN 
        (put the drug name into Rank A List) 
     ELSE IF (the drug name in either CBR or Bayesian reasoning) THEN 
        (put the drug name into Rank B List) 
     ELSE IF (the drug name in not in either CBR or Bayesian reasoning) THEN 
        (put the drug name into Rank C List) 
    END IF 
END FOR 
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Report the results 
Fig. 5. Algorithm of rule-based results aggregator 
 
 
Fig. 6. Rule-based results aggregator 
 
 
Fig. 7. Phases in an illustrated example 
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Fig. 8. Diagnosis of medical expert 
 
 
Fig. 9. An example case and the proposed solution 
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Fig. 10. An example conditional probability of drug prescribed 
 
 
Fig. 11. The recommended medical prescription list produced in HKSMP 
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Fig. 12. The experiment setup for measuring the retrieval correctness of HKSMP 
 
 
Fig. 13. The experiment setup for measuring the hit rate of HKSMP 
 
30 
 
List of Tables: 
 
Table 1: Summary of the case attributes 
Attribute Possible values 
Patient number  Unique ID (e.g. 34458, 32251, 1121) 
Age  Positive Integer (1-100) 
Sex  M, F 
Body Weight(kg)  Positive Integer (1-100) 
Height(cm)  Positive Integer (1-250) 
Last Record  Positive Integer (today – last treatment date) 
Number of days of sick leave Positive Integer (0-30) 
Payment Positive Integer (20-1000) 
Diagnosis Multi-value  ( },...,,{ RhinitisritisGastroenteURTI ) 
Symptoms Multi-value  ( },...,,{ eRunningNosCoughFever ) 
Days of medication Positive Integer (0-5) 
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Table 2: User feedback for the HKSMP performance 
 Very Dis
-satisfied
  
Dissatisfied Normal  Satisfied Very  
Satisfied 
Overall system performance 
Data input 0% 10% 20% 45% 25% 
Information retrieval 0% 0% 25% 50% 25% 
Decision support function 0% 15% 25% 40% 20% 
      
Data input 
Efficiency  
(compared with the old 
process) 
0% 5% 20% 50% 25% 
Simplicity 0% 10% 45% 30% 15% 
Design of user interface 0% 10% 30% 30% 30% 
      
Information retrieval 
Correctness of content 0% 25% 30% 20% 25% 
Sufficiency of content 0% 15% 25% 40% 20% 
Ease to understanding 0% 0% 40% 50% 10% 
      
Decision support function 
Efficiency  
(compared with the old 
process) 
0% 0% 30% 45% 25% 
Usefulness of prescription 
advice 
0% 15% 40% 25% 20% 
 
 
Table 3: A comparison of retrieval correctness of CBR, Bayesian reasoning and 
HKSMP among the 500 medical cases 
Number of 
suggested 
medicines 
CBR Bayesian reasoning HKSMP 
No. of learning cases No. of learning cases No. of learning cases 
100 200 300 400 500 100 200 300 400 500 100 200 300 400 500 
5 0.20 0.24 0.27 0.30 0.37 0.27 0.27 0.28 0.29 0.30 0.49 0.50 0.53 0.54 0.56 
6 0.29 0.32 0.35 0.38 0.41 0.50 0.51 0.53 0.53 0.54 0.59 0.60 0.62 0.62 0.64 
7 0.52 0.54 0.55 0.57 0.58 0.69 0.71 0.72 0.72 0.73 0.80 0.80 0.83 0.85 0.86 
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Table 4: Evaluation of medicines selected in different ranks of HKSMP 
 Rank A Rank B Rank C 
Average hit rate 1.40 1.87 1.47 
Standard Derivation 0.81 1.01 0.90 
Minimum number of medicine 
retrieved 
0 0 0 
Maximum number of medicine 
retrieved 
2 4 3 
 
 
 
 
